Pharma Stocks

A Look At Pharma Mar (BME:PHM) Valuation As Dividend Proposal Puts Shareholder Returns In Focus

Pharma Mar (BME:PHM) has proposed a dividend of €1.00 per share. This corporate action directly affects potential cash returns for…

Read More »

Assessing Supernus Pharmaceuticals (SUPN) Valuation After Recent Share Price Weakness And Pipeline Progress

Recent performance context for Supernus Pharmaceuticals Without a single headline event driving attention today, Supernus Pharmaceuticals (SUPN) is on some…

Read More »

Royalty Pharma (RPRX) Valuation Check After Strong Share Price Momentum And Royalty Growth Potential

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors…

Read More »

MRK Stock Gains After CHMP Backs Keytruda Combo for Bladder Cancer

Shares of Merck MRK rose nearly 6% on Friday after the company announced that the EMA’s Committee for Medicinal Products…

Read More »

Spotlight On Atea Pharmaceuticals And 2 Other Prominent Penny Stocks

Over the last 7 days, the market has risen 1.1%, with a notable 29% increase over the past year and…

Read More »

Margin pressure, slower growth outlook may cap upside for Sun Pharma stock

ET Intelligence Group: Sun Pharmaceutical Industries recorded double-digit growth in revenue and net profit for the March quarter; however, operating…

Read More »

Assessing NervGen Pharma (NasdaqCM:NGEN) Valuation After Its $60 Million Follow On Equity Offering

NervGen Pharma (NGEN) has drawn fresh attention after completing a follow on public equity offering of approximately $60 million, including…

Read More »

Looking to Buy Bristol Myers Squibb Stock on the Dip? Read This First.

Bristol Myers Squibb‘s (BMY 0.15%) shares are rebounding after sinking roughly 11%. However, the big pharma stock remains below the…

Read More »

Stocks to Watch for May 25: Hindalco, Eicher Motors, Divi’s Labs, Torrent Pharma, Lupin and more

1 / 12 Hindalco Industries Ltd | The Aditya Birla Group metals flagship reported a sharp rise in standalone fourth-quarter…

Read More »

AFT Pharmaceuticals Limited Just Missed Earnings – But Analysts Have Updated Their Models

It’s been a pretty great week for AFT Pharmaceuticals Limited (NZSE:AFT) shareholders, with its shares surging 11% to NZ$3.88 in…

Read More »